相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Design and characterization of a heterocyclic electrophilic fragment library for the discovery of cysteine-targeted covalent inhibitors
A. Keeley et al.
MEDCHEMCOMM (2019)
Practical application of ligand efficiency metrics in lead optimisation
James S. Scott et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Structure-based design of targeted covalent inhibitors
Richard Lonsdale et al.
CHEMICAL SOCIETY REVIEWS (2018)
Mapping the Efficiency and Physicochemical Trajectories of Successful Optimizations
Robert J. Young et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Scaffold-Hopping Approach To Discover Potent, Selective, and Efficacious Inhibitors of NF-kappa B Inducing Kinase
Nicole Blaquiere et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
The NF-κB subunit RelB controls p100 processing by competing with the kinases NIK and IKK1 for binding to p100
Amanda J. Fusco et al.
SCIENCE SIGNALING (2016)
The NF-κB subunit RelB controls p100 processing by competing with the kinases NIK and IKK1 for binding to p100
Amanda J. Fusco et al.
SCIENCE SIGNALING (2016)
The IκB kinase complex in NF-κB regulation and beyond
Michael Hinz et al.
EMBO REPORTS (2014)
Discovery of a Potent and Selective EGFR Inhibitor (AZD9291) of Both Sensitizing and T790M Resistance Mutations That Spares the Wild Type Form of the Receptor
M. Raymond V. Finlay et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Pharmacological and genomic profiling identifies NF-kappa B-targeted treatment strategies for mantle cell lymphoma
Rami Rahal et al.
NATURE MEDICINE (2014)
The role of ligand efficiency metrics in drug discovery
Andrew L. Hopkins et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Inhibiting NF-κB-inducing kinase (NIK): Discovery, structure-based design, synthesis, structure-activity relationship, and co-crystal structures
Kexue Li et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Hodgkin lymphoma requires stabilized NIK and constitutive RelB expression for survival
Stella M. Ranuncolo et al.
BLOOD (2012)
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia
Davide Rossi et al.
BLOOD (2012)
Structure of the Nuclear Factor κB-inducing Kinase (NIK) Kinase Domain Reveals a Constitutively Active Conformation
Jinsong Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Free Energy Calculations by the Molecular Mechanics Poisson-Boltzmann Surface Area Method
Nadine Homeyer et al.
MOLECULAR INFORMATICS (2012)
The Crystal Structure of the Catalytic Domain of the NF-κB Inducing Kinase Reveals a Narrow but Flexible Active Site
Gladys de Leon-Boenig et al.
STRUCTURE (2012)
Imidazo[1,5-a]quinoxalines as irreversible BTK inhibitors for the treatment of rheumatoid arthritis
Kyung-Hee Kim et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma
Davide Rossi et al.
BLOOD (2011)
A mild and efficient method for the selective deprotection of silyl ethers using KF in the presence of tetraethylene glycol
Hailong Yan et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2011)
Classical and/or alternative NF-κB pathway activation in multiple myeloma
Yulia N. Demchenko et al.
BLOOD (2010)
The NF-κB Family of Transcription Factors and Its Regulation
Andrea Oeckinghaus et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2009)
Mechanism-Based Inhibition: Deriving KI and kinact Directly from Time-Dependent IC50 Values
Ben-Fillippo Krippendorff et al.
JOURNAL OF BIOMOLECULAR SCREENING (2009)
Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-κB signaling
Sivakumar Vallabhapurapu et al.
NATURE IMMUNOLOGY (2008)
Noncanonical NF-kappa B activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK
Brian J. Zarnegar et al.
NATURE IMMUNOLOGY (2008)
Cross-coupling methods for the large-scale preparation of an imidazole-thienopyridine:: Synthesis of [2-(3-methyl-3H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yl]-(2-methyl-1H-indol-5-yl)-amine
JA Ragan et al.
ORGANIC PROCESS RESEARCH & DEVELOPMENT (2003)
分享论文
